Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Our most recent BPC-157 certificate of analysis from Sports Technology Labs, available as a PDF download, confirms this, with a purity of 99.85%
Others: Roche, J&J, Sanofi, and AZ have had GLP-1 efforts (some deprioritized) or new dual/triple agonists in development (e.g., Roches pipeline includes a dual agonist announced in 2024)
Slowing escalation schedules, reducing maintenance doses, or switching between compounded formulations (oral versus injectable) can reduce symptom burden while maintaining therapeutic benefit
Will my insurance cover the costs
US$ 20.95
US$ 26.67
US$ 21.52
